title: Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults?
authors.forename: J K
authors.initials: JK
authors.lastname: Ferguson
authors.forename: M J
authors.initials: MJ
authors.lastname: Hensley
mesh_terms: D000328:Adult; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001315:Australia; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000635:transmission; D004363:Drug Utilization; D006801:Humans; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000635:transmission; D016896:Treatment Outcome
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins